tm
Seeing Is Believing
tm
Seeing Is Believing
SGMT is currently covered by 6 analysts with an average price target of $24.6. This is a potential upside of $15.76 (233.79%) from yesterday's end of day stock price of $7.37.
Sagimet Biosciences Series A Common Stock's activity chart (see below) currently has 10 price targets and 29 ratings on display. The stock rating distribution of SGMT is 90% BUY and 10% HOLD.
Analysts average stock forecasts to be materialized ratio is 14.29% with an average time for these price targets to be met of 28 days.
Highest price target for SGMT is $49, Lowest price target is $8, average price target is $24.6.
Most recent stock forecast was given by from JMP on 19-May-2026. First documented stock forecast 08-Aug-2023.
Currently out of the existing stock ratings of SGMT, 9 are a BUY (90%), 1 are a HOLD (10%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Aug-2023
$12
$4.94 (69.97%)
$31
1 months 24 days ago
(19-May-2026)
0/3 (0%)
$5.46 (83.49%)
Buy Since 24-Jul-2025
$49
$41.94 (594.05%)
$28
2 months 9 days ago
(04-May-2026)
0/3 (0%)
$41.1 (520.25%)
Buy Since 07-Aug-2025
$29
4 months 2 days ago
(11-Mar-2026)
0/2 (0%)
$22.44 (342.07%)
Hold Since 28-Jan-2026
$8
$0.94 (13.31%)
$12
5 months 15 days ago
(28-Jan-2026)
1/2 (50%)
$2.14 (36.52%)
89
Buy Since 06-Jun-2025
$26
$18.94 (268.27%)
$27
10 months 25 days ago
(18-Aug-2025)
0/2 (0%)
$18.45 (244.37%)
What is SGMT (Sagimet Biosciences Series A Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on SGMT (Sagimet Biosciences Series A Common Stock) with a proven track record?
Which analyst has the most public recommendations on SGMT (Sagimet Biosciences Series A Common Stock)?
Which analyst is the currently most bullish on SGMT (Sagimet Biosciences Series A Common Stock)?
Which analyst is the currently most reserved on SGMT (Sagimet Biosciences Series A Common Stock)?
